Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | AKKARAJU SRINIVAS
(Director) |
U | Common Stock | D | 678575 | $19.00 - $19.00 | $12,892,925 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | AKKARAJU SRINIVAS
(Director) |
D | Common Stock | D | 8111 | $19.00 - $19.00 | $154,109 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Venezia Rocco
(Chief Accounting Officer) |
U | Common Stock | D | 10782 | $19.00 - $19.00 | $204,858 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Venezia Rocco
(Chief Accounting Officer) |
D | Common Stock | D | 14669 | $19.00 - $19.00 | $278,711 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Berrey M Michelle
(President, R&D and CMO) |
U | Common Stock | D | 28349 | $19.00 - $19.00 | $538,631 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Berrey M Michelle
(President, R&D and CMO) |
D | Common Stock | D | 51790 | $19.00 - $19.00 | $984,010 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Fundaro Paolo
(Director) |
U | Common Stock | D | 35794 | $19.00 - $19.00 | $680,086 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Fundaro Paolo
(Director) |
D | Common Stock | D | 8111 | $19.00 - $19.00 | $154,109 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Richardson Linda M
(EVP & Chief Commercial Officer) |
U | Common Stock | D | 16706 | $19.00 - $19.00 | $317,414 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Richardson Linda M
(EVP & Chief Commercial Officer) |
D | Common Stock | D | 26585 | $19.00 - $19.00 | $505,115 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Benatti Luca
(Director) |
U | Common Stock | D | 25487 | $19.00 - $19.00 | $484,253 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Benatti Luca
(Director) |
D | Common Stock | D | 8111 | $19.00 - $19.00 | $154,109 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | SBLENDORIO GLENN
(Director) |
U | Common Stock | D | 23447 | $19.00 - $19.00 | $445,493 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | SBLENDORIO GLENN
(Director) |
D | Common Stock | D | 8111 | $19.00 - $19.00 | $154,109 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | SANTINI GINO
(Director) |
U | Common Stock | D | 23645 | $19.00 - $19.00 | $449,255 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | SANTINI GINO
(Director) |
D | Common Stock | D | 8111 | $19.00 - $19.00 | $154,109 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Miller-Rich Nancy
(Director) |
U | Common Stock | D | 22304 | $19.00 - $19.00 | $423,776 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Miller-Rich Nancy
(Director) |
D | Common Stock | D | 8111 | $19.00 - $19.00 | $154,109 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | ROSA-BJORKESON DA...
(Director) |
U | Common Stock | D | 14766 | $19.00 - $19.00 | $280,554 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | ROSA-BJORKESON DA...
(Director) |
D | Common Stock | D | 11625 | $19.00 - $19.00 | $220,875 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Gottesdiener Keit...
(Director) |
U | Common Stock | D | 24719 | $19.00 - $19.00 | $469,661 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Gottesdiener Keit...
(Director) |
D | Common Stock | D | 8111 | $19.00 - $19.00 | $154,109 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Ford David A
(Chief Human Resources Officer) |
U | Common Stock | D | 15038 | $19.00 - $19.00 | $285,722 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Ford David A
(Chief Human Resources Officer) |
D | Common Stock | D | 21400 | $19.00 - $19.00 | $406,600 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Freedberg Jared
(General Counsel) |
U | Common Stock | D | 22681 | $19.00 - $19.00 | $430,939 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Freedberg Jared
(General Counsel) |
D | Common Stock | D | 33762 | $19.00 - $19.00 | $641,478 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | BRADBURY DANIEL
(Director) |
U | Common Stock | D | 31360 | $19.00 - $19.00 | $595,840 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | BRADBURY DANIEL
(Director) |
D | Common Stock | D | 8111 | $19.00 - $19.00 | $154,109 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Durso Jerome Bene...
(CEO) |
U | Common Stock | D | 51815 | $19.00 - $19.00 | $984,485 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Durso Jerome Bene...
(CEO) |
D | Common Stock | D | 102825 | $19.00 - $19.00 | $1,953,675 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Pruzanski Mark
(Director) |
U | Common Stock | D | 618894 | $19.00 - $19.00 | $11,758,986 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Saik Andrew
(EVP & Chief Financial Officer) |
U | Common Stock | D | 23021 | $19.00 - $19.00 | $437,399 |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | Saik Andrew
(EVP & Chief Financial Officer) |
D | Common Stock | D | 45244 | $19.00 - $19.00 | $859,636 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |